...
首页> 外文期刊>Journal of cardiovascular electrophysiology >Maternal focal atrial tachycardia during pregnancy: A systematic review
【24h】

Maternal focal atrial tachycardia during pregnancy: A systematic review

机译:怀孕期间孕产妇焦细胞心动过速:系统审查

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Introduction The presentation and optimal management of maternal focal atrial tachycardia (AT) during pregnancy are unknown. The objective of this study is to conduct a comprehensive summary of the existing evidence. Methods and Results A systematic review of all reported cases of maternal focal AT during pregnancy was performed. The primary search queried PubMed using the MeSH terms "supraventricular tachycardia" and "pregnancy." A stepwise ancillary search included article bibliographies, citations listed by the Google internet search engine, and PubMed using the MeSH terms "atrial tachycardia" and "pregnancy." In total, 28 citations that described 32 patients were retrieved. A case from our institution was added. Detailed information was available for 30 patients. Clinical characteristics at presentation included a mean +/- standard deviation of 28.3 +/- 5.7 years for maternal age and 24.6 +/- 7.7 weeks for gestation age. Suspected tachycardia-induced cardiomyopathy was present in 20 of 30 (67%) patients and left ventricular ejection fraction improved in 15 of 15 (100%) patients with follow-up measurements. Medication failure was common. Focal AT resolved spontaneously after delivery in eight of nine (89%) patients treated with only medications. Automaticity was suggested by discrete electrograms at sites of origin and lack of reported inducibility and termination with programmed stimulation in all patients who underwent electrophysiology studies. There were nine cases of successful catheter ablation with zero fluoroscopy since 2010. Conclusions Automaticity is the dominant mechanism for patients with maternal focal AT during pregnancy. Catheter ablation with zero fluoroscopy is an emerging therapy for medically refractory cases.
机译:引言孕期母亲局灶性房性心动过速(AT)的表现和最佳治疗尚不清楚。本研究的目的是对现有证据进行全面总结。方法和结果对所有报告的妊娠期母亲局灶性AT病例进行系统回顾。主要搜索使用网格术语“室上性心动过速”和“妊娠”查询PubMed逐步辅助搜索包括文章参考书目、谷歌互联网搜索引擎列出的引文,以及使用网状词“房性心动过速”和“妊娠”的PubMed共检索到28篇描述32名患者的引文。增加了我们机构的一个案例。有30名患者的详细信息。临床特征包括平均+/-标准偏差为28.3+/-5.7岁(母龄)和24.6+/-7.7周(孕龄)。30名患者中有20名(67%)患者存在疑似心动过速诱发的心肌病,15名(100%)患者中有15名(100%)患者的左室射血分数改善。药物治疗失败很常见。9名(89%)仅接受药物治疗的患者中有8名在分娩后出现局灶性AT自行消失。在所有接受电生理研究的患者中,起源部位的离散电图以及缺乏程序性刺激诱导和终止的报告表明了自动性。自2010年以来,有9例导管消融成功且无透视。结论自动性是妊娠期母亲局灶性AT患者的主要机制。零透视导管消融术是治疗难治性疾病的一种新兴疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号